National Comprehensive Cancer Network



About NCCN

Soft Tissue Sarcoma Panel - Disclosures as of 5/18/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Robert S. Benjamin, MD

Amgen Inc.

Amgen Inc.

Johnson & Johnson;
Merck & Co., Inc.;
Pfizer Inc.

None

3/28/2012

Marilyn M. Bui, MD, PhD

None

Novartis Pharmaceuticals Corporation

None

None

5/28/2012

Ephraim S. Casper, MD

None

None

None

None

8/16/2012

Ernest U. Conrad III, MD

None

None

None

None

3/21/2012

Thomas F. DeLaney, MD

None

None

None

None

9/12/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristen N. Ganjoo, MD

None

None

None

None

8/17/2012

Suzanne George, MD

Bayer HealthCare;
Eisai Inc.;
Johnson & Johnson

Pfizer Inc.

None

None

3/8/2012

Ricardo J. Gonzalez, MD

None

None

None

None

10/14/2011

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Martin J. Heslin, MD

None

None

None

None

10/8/2012

John M. Kane III, MD

None

None

None

None

9/8/2012

Joel Mayerson, MD

Millennium Pharmaceuticals, Inc.

None

None

None

4/30/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Sean V. McGarry, MD

None

None

None

Musculoskeletal Transplant Foundation

8/8/2012

Nicole McMillian, MS

None

None

None

None

3/27/2013

Christian Meyer, MD, PhD

None

None

None

None

9/11/2012

Richard J. O'Donnell, MD

None

None

None

None

3/27/2013

I. Benjamin Paz, MD

Agendia BV

None

None

None

10/11/2011

John D. Pfeifer, MD, PhD

None

None

None

None

9/30/2011

R. Lor Randall, MD, FACS

Children`s Oncology Group;
Connective tissue Oncology Society;
Musculoskeletal Tumor Society

Biomet;
Musculoskeletal Transplant Foundation

None

None

3/27/2013

Richard F. Riedel, MD

ARIAD Pharmaceuticals, Inc.;
Eisai Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
ASTEX;
CytRx Corporation;
Infinity Pharmaceuticals;
Threshold

Novartis Pharmaceuticals Corporation

None

None

9/11/2012

Scott Schuetze, MD, PhD

Amgen Inc.;
Johnson & Johnson;
Novartis Pharmaceuticals Corporation;
AB Sciences;
SARC;
Ziopharm

Novartis Pharmaceuticals Corporation;
DAVA pharmaceuticals;
Ziopharm

None

None

9/4/2012

Karen D. Schupak, MD

None

None

None

None

9/5/2012

Herbert S. Schwartz, MD

None

None

None

Musculoskeletal Transplant Foundation

10/10/2012

Hema Sundar, PhD

None

None

None

None

2/25/2013

Brian A. Van Tine, MD, PhD

None

Bayer HealthCare

None

None

8/19/2012

Margaret von Mehren, MD

Eisai Inc.;
Johnson & Johnson;
Merck & Co., Inc.;
Morphotek Inc.;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
OSI Pharmaceuticals, Inc.;
Arog Pharmaceuticals;
Astex;
Infinity;
Pharma Mar;
Sarcoma Alliance for Research through Collaboration;
Pfizer Inc.;
Synta Pharmaceuticals Corp.

Eisai Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Pharma Mar;
Pfizer Inc.

None

None

8/6/2012

Jeffrey D. Wayne, MD

None

Novartis Pharmaceuticals Corporation

None

None

8/29/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved